These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12919753)
41. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein. Mustafa AS; Lundin KE; Meloen RH; Oftung F Clin Exp Immunol; 2000 Apr; 120(1):85-92. PubMed ID: 10759768 [TBL] [Abstract][Full Text] [Related]
42. Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. Herr W; Ranieri E; Gambotto A; Kierstead LS; Amoscato AA; Gesualdo L; Storkus WJ Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12033-8. PubMed ID: 10518571 [TBL] [Abstract][Full Text] [Related]
43. The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9. James EA; Moustakas AK; Bui J; Nouv R; Papadopoulos GK; Kwok WW J Immunol; 2009 Sep; 183(5):3249-58. PubMed ID: 19648278 [TBL] [Abstract][Full Text] [Related]
44. Identification of Streptococcus mutans PAc peptide motif binding with human MHC class II molecules (DRB1*0802, *1101, *1401 and *1405). Senpuku H; Yanagi K; Nisizawa T Immunology; 1998 Nov; 95(3):322-30. PubMed ID: 9824493 [TBL] [Abstract][Full Text] [Related]
45. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582 [TBL] [Abstract][Full Text] [Related]
46. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Ovsyannikova IG; Jacobson RM; Ryan JE; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA Immunogenetics; 2005 Feb; 56(11):798-807. PubMed ID: 15712014 [TBL] [Abstract][Full Text] [Related]
47. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238 [TBL] [Abstract][Full Text] [Related]
48. Role of three quantitatively dominant endogenous peptides from HLA-DRB1*0401 molecules in class II specific alloreactivity. Adibzadeh M; Friccius H; Bornhak S; Max H; Hambrecht A; Sansom D; Kalbacher H; Schenk A; Pohla H; Pawelec G Transpl Immunol; 1994 Dec; 2(4):293-9. PubMed ID: 7704539 [TBL] [Abstract][Full Text] [Related]
50. A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules. Robbins PA; Rota PA; Shapiro SZ Int Immunol; 1997 Jun; 9(6):815-23. PubMed ID: 9199964 [TBL] [Abstract][Full Text] [Related]
51. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757 [TBL] [Abstract][Full Text] [Related]
52. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222 [TBL] [Abstract][Full Text] [Related]
53. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982 [TBL] [Abstract][Full Text] [Related]
54. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules. Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736 [TBL] [Abstract][Full Text] [Related]
55. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. Wilson CC; Palmer B; Southwood S; Sidney J; Higashimoto Y; Appella E; Chesnut R; Sette A; Livingston BD J Virol; 2001 May; 75(9):4195-207. PubMed ID: 11287569 [TBL] [Abstract][Full Text] [Related]
56. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807 [TBL] [Abstract][Full Text] [Related]
57. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Geluk A; Taneja V; van Meijgaarden KE; Zanelli E; Abou-Zeid C; Thole JE; de Vries RR; David CS; Ottenhoff TH Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10797-802. PubMed ID: 9724784 [TBL] [Abstract][Full Text] [Related]
58. Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling. James EA; Moustakas AK; Berger D; Huston L; Papadopoulos GK; Kwok WW Mol Immunol; 2008 May; 45(9):2651-9. PubMed ID: 18276010 [TBL] [Abstract][Full Text] [Related]
59. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534 [TBL] [Abstract][Full Text] [Related]
60. NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. Zarour HM; Maillere B; Brusic V; Coval K; Williams E; Pouvelle-Moratille S; Castelli F; Land S; Bennouna J; Logan T; Kirkwood JM Cancer Res; 2002 Jan; 62(1):213-8. PubMed ID: 11782380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]